Japanese Journal of Gastroenterology最新文献_第4页

[Image-enhanced endoscopy and AI in upper gastrointestinal screening]. [图像增强内窥镜与人工智能在上消化道筛查中的应用]。

Japanese Journal of Gastroenterology Pub Date : 2025-01-01 DOI: 10.11405/nisshoshi.122.112

Toshiaki Hirasawa, Sho Suzuki, Tomohiro Tada

引用次数: 0

[Efforts to reduce parenteral support in short bowel syndrome]. [努力减少肠短综合征的肠外支持]。

Japanese Journal of Gastroenterology Pub Date : 2025-01-01 DOI: 10.11405/nisshoshi.122.178

Toshiyuki Sato, Yuki Horio, Shinichiro Shinzaki

引用次数: 0

[Imaging diagnosis of IPMN]. 【IPMN影像学诊断】。

Japanese Journal of Gastroenterology Pub Date : 2025-01-01 DOI: 10.11405/nisshoshi.122.9

Eizaburo Ohno, Yoshiki Hirooka

引用次数: 0

[Efficacy and safety of ferric carboxymaltose in patients with inflammatory bowel disease]. 【羧麦芽糖铁治疗炎症性肠病患者的疗效和安全性】。

Japanese Journal of Gastroenterology Pub Date : 2025-01-01 DOI: 10.11405/nisshoshi.122.196

Yusuke Ozeki, Jun Kato, Yuki Ohta, Takashi Taida, Ryosuke Horio, Michiko Sonoda, Tatsuya Kaneko, Kenichiro Okimoto, Keiko Saito, Tomoaki Matsumura, Naoya Kato

{"title":"[Efficacy and safety of ferric carboxymaltose in patients with inflammatory bowel disease].","authors":"Yusuke Ozeki, Jun Kato, Yuki Ohta, Takashi Taida, Ryosuke Horio, Michiko Sonoda, Tatsuya Kaneko, Kenichiro Okimoto, Keiko Saito, Tomoaki Matsumura, Naoya Kato","doi":"10.11405/nisshoshi.122.196","DOIUrl":"10.11405/nisshoshi.122.196","url":null,"abstract":"Iron deficiency anemia (IDA) is a prevalent complication in patients with inflammatory bowel disease (IBD). Ferric carboxymaltose (FCM) is a new intravenous iron formation that has been available for IDA in Japan since 2020. The present study aimed to investigate the efficacy and safety of FCM in patients with IBD and IDA. This single-center retrospective study included 41 patients with IBD treated with FCM at our hospital from September 2020 to June 2023. The FCM administered dose was 500mg in 28 patients, 1000mg in 7 patients, and >1500mg in 6 patients. The median hemoglobin level improved from 9.8g/dL to 11.8g/dL at 16 weeks after the first FCM administration during the study period. Median change in hemoglobin levels 16 weeks after the first FCM dose did not significantly differ between patients with low C-reactive protein (CRP) levels (CRP ≤0.5mg/dL;n=31) and those with high CRP levels (CRP >0.5mg/dL;n=10) (2.2g/dL vs. 1.7g/dL, p=0.94). Adverse events were observed in 6 patients, including hypophosphatemia in 2 (4.9%) and osteomalacia in 1 (2.4%). FCM administration in patients with IBD is expected to improve anemia even with fewer administrations.","PeriodicalId":35808,"journal":{"name":"Japanese Journal of Gastroenterology","volume":"122 3","pages":"196-205"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143587548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Hemosuccus pancreaticus caused by pancreatic cancer treated with radiation therapy for hemostasis]. [放疗止血治疗胰腺癌引起的胰脏出血]。

Japanese Journal of Gastroenterology Pub Date : 2025-01-01 DOI: 10.11405/nisshoshi.122.130

Hirofumi Harima, Harumi Suehiro, Michitaka Kawano, Tadasuke Hanazono, Kenji Mori, Yasuyo Chochi, Taro Takami

{"title":"[Hemosuccus pancreaticus caused by pancreatic cancer treated with radiation therapy for hemostasis].","authors":"Hirofumi Harima, Harumi Suehiro, Michitaka Kawano, Tadasuke Hanazono, Kenji Mori, Yasuyo Chochi, Taro Takami","doi":"10.11405/nisshoshi.122.130","DOIUrl":"10.11405/nisshoshi.122.130","url":null,"abstract":"A 67-year-old female patient, with a chief complaint of melena, was referred to our hospital because of a pancreatic tumor. A blood assessment revealed anemia with a hemoglobin (Hb) level of 7.7g/dL. Contrast-enhanced computed tomography (CT) detected a large pancreatic tail tumor and liver metastasis. Upper endoscopy demonstrated bile juice containing a blood-like red in the duodenum. We confirmed the pancreatic cancer diagnosis via endoscopic ultrasound-guided fine needle aspiration (EUS-FNA). CT after the procedure indicated a hematoma in the pancreatic tumor. The patient required frequent blood transfusions due to severe anemia. The second upper endoscopy demonstrated bleeding from the papilla of Vater. We diagnosed the patient with hemosuccus pancreaticus (HP). Pancreatic cancer, not hematoma, was considered to cause HP because we detected blood, such as red bile juice, before EUS-FNA. Her Hb levels decreased although she underwent coil embolization of the left gastric artery and splenic artery branches. We considered surgical treatment to stop the bleeding, but we abandoned surgery because of the pancreatic cancer invasion of the surrounding organs. We then attempted radiation therapy. Her Hb level stopped decreasing following treatment. She did not need frequent blood transfusions until she received radiation therapy and died 3 months later. The autopsy revealed a final diagnosis of anaplastic carcinoma. HP is an uncommon disease caused by bleeding from the papilla of Vater. HP is frequently caused by chronic pancreatitis, but it is also induced by a pancreatic tumor. Most HP cases received interventional radiology and surgical treatment. Here, we describe a case of HP caused by pancreatic cancer in which radiation therapy was effective for hemostasis.","PeriodicalId":35808,"journal":{"name":"Japanese Journal of Gastroenterology","volume":"122 2","pages":"130-137"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143383500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Pathogenesis and treatment of primary sclerosing cholangitis -Role of the gut microbiota]. 原发性硬化性胆管炎的发病机制和治疗——肠道菌群的作用。

Japanese Journal of Gastroenterology Pub Date : 2025-01-01 DOI: 10.11405/nisshoshi.122.235

Haruka Okada, Takanori Kanai, Nobuhiro Nakamoto

引用次数: 0

[Primary sclerosing cholangitis in children]. [儿童原发性硬化性胆管炎]。

Japanese Journal of Gastroenterology Pub Date : 2025-01-01 DOI: 10.11405/nisshoshi.122.256

Shuichiro Umetsu

引用次数: 0

[Drug-induced liver injury due to asymptomatically discovered Saire-to: a case report]. 【无症状发现的sare -to致药物性肝损伤1例报告】。

Japanese Journal of Gastroenterology Pub Date : 2025-01-01 DOI: 10.11405/nisshoshi.122.216

Soshi Oyama, Kazuo Okumoto, Shotaro Akiba, Hidekazu Horiuchi, Shigemi Hachinohe

引用次数: 0

[The utilize of image enhanced endoscopy for detecting gastric neoplasia]. 影像增强内镜在胃肿瘤检查中的应用

Japanese Journal of Gastroenterology Pub Date : 2025-01-01 DOI: 10.11405/nisshoshi.122.103

Takeshi Yasuda, Kohei Takizawa

引用次数: 0

[Liver transplantation for primary sclerosing cholangitis:current status and challenges]. 肝移植治疗原发性硬化性胆管炎：现状和挑战。

Japanese Journal of Gastroenterology Pub Date : 2025-01-01 DOI: 10.11405/nisshoshi.122.269

Shintaro Yagi, Hironori Haga, Hiroyuki Isayama

引用次数: 0